Pharmacovigilance is an activity of primary relevance for pharmaceutical companies. Adequate competence in different scientific areas is needed in order to comply with the different national and European requirements.

Many companies are setting up a pharmacovigilance unit or, in most cases, they charge outside companies with the task of following this strategic area.

Di Renzo Pharmacovigilance Unit cooperates with Di Renzo Regulatory Affairs, seated in Rome and active in the Regulatory Affairs for more than 25 years.